Clinical Trial Update: Two Dose Levels of Privigen in Pediatric CIDP [Phase 4]

View source ↗

Summary

A Phase 4 pediatric CIDP trial evaluating two dose levels of Privigen (intravenous immunoglobulin) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Drugs mentioned

• Privigen (intravenous immunoglobulin (IVIG))

Snippet

Sponsor: CSL Behring | Conditions: Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Phase 4 | Status: RECRUITING